Bruce P. Connop

Director/Board Member at IBEX TECHNOLOGIES

57 year

Health Technology

Commercial Services

Consumer Services

Profile

Bruce P.
Connop is an Independent Director at IBEX Technologies, Inc. since 2017.
He is also the Vice President-Preclinical Research & Development at Active Pass Pharmaceuticals, Inc. since 1999.
Previously, he worked as the VP-Non Clinical & Pharmaceutical Development at Transition Therapeutics, Inc. from 2006 to 2012.
Dr. Connop holds a doctorate degree from Queen's University.

Bruce P. Connop active positions

Companies	Position	Start
IBEX TECHNOLOGIES	Director/Board Member	2017-10-10
Active Pass Pharmaceuticals, Inc. Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases	Chief Tech/Sci/R&D Officer	1998-12-31

All active positions of Bruce P. Connop

Former positions of Bruce P. Connop

Companies	Position	End
TRANSITION THERAPEUTICS INC	Corporate Officer/Principal	-

See the detail of Bruce P. Connop's experience

Training of Bruce P. Connop

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bruce P. Connop's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Transition Therapeutics, Inc. Transition Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical development company that manufactures novel therapeutics for CNS, metabolic diseases and androgen deficiency indications	Commercial Services
IBEX Technologies, Inc. IBEX Technologies, Inc. Pharmaceuticals: OtherHealth Technology Produces proprietary enzymes and reagents for diagnostic tests	Health Technology
Queen's University Queen's University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Active Pass Pharmaceuticals, Inc. Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases	Health Technology